These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 28804051)

  • 1. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
    Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
    Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.
    Morris MD; Andrew E; Tan JY; Maher L; Hoff C; Darbes L; Page K
    PLoS One; 2019; 14(5):e0217811. PubMed ID: 31150518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.
    Evans JL; Morris MD; Yu M; Page K; Hahn JA
    Drug Alcohol Depend; 2014 Sep; 142():239-44. PubMed ID: 25034898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More than just someone to inject drugs with: Injecting within primary injection partnerships.
    Morris MD; Bates A; Andrew E; Hahn J; Page K; Maher L
    Drug Alcohol Depend; 2015 Nov; 156():275-281. PubMed ID: 26460140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
    Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
    PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
    Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
    Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.
    Morris MD; Montgomery ME; Briceno A; Evans JL; Andrew EVW; Page K; Hahn JA
    Subst Use Misuse; 2018 Jul; 53(8):1281-1287. PubMed ID: 29286888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
    Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
    J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
    Bryant J; Brener L; Hull P; Treloar C
    Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
    Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J;
    J Epidemiol Community Health; 2015 Aug; 69(8):745-52. PubMed ID: 25814695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.